Attention Deficit and Disruptive Behavior Disorders  >>  memantine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT00586573: Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

Completed
4
34
US
memantine hydrochloride, Namenda
Massachusetts General Hospital
ADHD
10/09
10/09
FOGG-I, NCT01108029 / 2008-008210-38: Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Completed
4
28
Europe
memantine, EBIXA, placebo
University Hospital, Lille
Parkinson's Disease, Gait Disorders, Neurologic
09/10
10/10

Download Options